Showing results (331-340 of 1,371) with videos related to
Sort By:
Pageof 138
Drug Development Research|December 3, 2022
Multitargeted C9-substituted ester and ether derivatives of berberrubine for Alzheimer's disease: Design, synthesis, biological evaluation, metabolic stability, and pharmacokineticsRinky Raghuvanshi, Ashiya Jamwal, Utpal Nandi, et al.Drug Development Research|December 5, 2022
Anlotinib improves bile duct ligature-induced liver fibrosis in rats via antiangiogenesis regulated by VEGFR2/mTOR pathwayJun Lei, Qing Li, Hongyan Xu, et al.Drug Development Research|June 24, 2022
Quercetin ameliorates salivary gland apoptosis and inflammation in primary Sjögren's syndrome through regulation of the leptin/OB-R signalingLihua Chang, Aibin Kong, Yun Guo, et al.Drug Development Research|June 25, 2022
The potential of developing a protective peptide-based vaccines against SARS-CoV-2Ahmed O Shalash, Istvan Toth, Mariusz SkwarczynskiDrug Development Research|May 22, 2019
Efficacy of a phenol derivative, isopropyl vanillate, as an anti-inflammatory agent: A new small molecule inhibitor of COX and neutrophil migrationKerolayne M Nogueira, Luan K M de Souza, Ana P de Oliveira, et al.Drug Development Research|October 8, 2021
Troxerutin regulates HIF-1α by activating JAK2/STAT3 signaling to inhibit oxidative stress, inflammation, and apoptosis of cardiomyocytes induced by H2 O2Hui Li, Min Yang, Danfei LouDrug Development Research|July 28, 2022
Synthesis, biological evaluation, and in silico studies of indole-tethered pyrazoline derivatives as anticancer agents targeting topoisomerase IIαKashif Haider, Shivani Sharma, Yuba Raj Pokharel, et al.Drug Development Research|August 17, 2010
Tat-Mediated Peptide Intervention in Analgesia and AnesthesiaFeng Tao, Roger A JohnsDrug Development Research|December 21, 2010
Ligand Binding Sensitivity of the Extracellular Loop Two of the Cannabinoid Receptor 1Alexander C Bertalovitz, Kwang H Ahn, Debra A KendallDrug Development Research|March 15, 2011
Next-Generation Antimalarial Drugs: Hybrid Molecules as a New Strategy in Drug DesignFrancis W Muregi, Akira IshihPageof 138